Hox Gene Regulation in Cancer Biology
Summary
Homeobox (HOX) genes encode a family of highly conserved transcription factors that establish positional identity during embryonic development and maintain tissue homeostasis in the adult. In cancer biology, aberrant HOX gene expression arises from genetic mutations, chromosomal rearrangements and epigenetic alterations such as DNA methylation and histone modification. Dysregulated HOX activity can drive oncogenic programmes by promoting uncontrolled proliferation, evasion of apoptosis, epithelial-to-mesenchymal transition and metastatic dissemination. Conversely, loss of tumour-suppressive HOX expression may disable differentiation cues and facilitate malignant transformation. HOX proteins often form higher-order complexes with TALE cofactors such as PBX and MEIS, enhancing DNA-binding specificity and recruiting chromatin remodellers. This interplay shapes tumour cell behaviour and influences the surrounding microenvironment, including immune infiltration and stromal interactions. A growing body of research has revealed that HOX-driven transcriptional networks intersect with cell cycle regulators, DNA-repair pathways and signalling cascades such as TGFβ and Wnt. These insights have yielded prognostic biomarkers and suggested novel intervention points, including small molecules that disrupt HOX–PBX dimerisation or modify aberrant epigenetic marks to restore balanced HOX expression. The global significance of HOX gene regulation lies in its potential to inform precision-medicine strategies across diverse malignancies and to illuminate fundamental principles of gene regulation in cancer.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Hox Gene Regulation in Cancer Biology publication trend
The graph below shows the total number of articles in hox gene regulation in cancer biology across all publications each year (not limited to Nature Index journals).
Technical terms
Homeobox (HOX) genes: Evolutionarily conserved transcription factors that specify positional identity during development and regulate target genes in adult tissues.
Epigenetic regulation: Modification of chromatin or DNA without altering the nucleotide sequence, affecting gene expression patterns.
Transcription factor: A protein that binds specific DNA sequences to activate or repress transcription of downstream genes.
DNA methylation: Addition of methyl groups to cytosine residues in DNA, commonly associated with gene silencing.
TALE cofactors (PBX/MEIS): Non-HOX homeodomain proteins that heterodimerise with HOX factors to increase DNA-binding specificity and regulatory potency.
Tumour microenvironment (TME): The complex milieu of cancer cells, stromal cells, immune infiltrates and extracellular matrix that influences tumour behaviour.
Chemoresistance: The acquired or intrinsic ability of cancer cells to survive cytotoxic chemotherapy through diverse molecular mechanisms.
References
- Effects of HOX family regulator-mediated modification patterns and immunity characteristics on tumor-associated cell type in endometrial cancer. Molecular Biomedicine (2024).
- The E2F1–HOXB9/PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer. The Journal of Pathology (2023).
- HOXB9 Overexpression Confers Chemoresistance to Ovarian Cancer Cells by Inducing ERCC-1, MRP-2, and XIAP. International Journal of Molecular Sciences (2023).
- Targeting HOX/PBX dimers in cancer. Oncotarget (2017).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Nature Index 2026 Cancer
Cancer incidence is on the rise. Countries are meeting the challenge in different ways, such as through nationwide action plans and broadening early detection programmes. However, coordinating these efforts to make them accessible, targeted and effective is a balancing act. In this supplement, we explore the factors that are shaping these first lines of defence and the research efforts that are informing them.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.